World's first 'home grown' African first-aid guidelines

A new set of evidence-based guidelines that comprehensively address how basic first responders should be trained to manage emergency situations in an African context has been released, published in this week's PLoS Medicine. The guidelines, which were developed by a panel of African-based experts and in conjunction with African Red Cross Societies, focus on first aid interventions requiring minimal or no equipment. They can be used by individuals and organisations involved in first aid training programmes in Africa, and an implementation guide is also available to help tailor the training materials to the local context and target group.

As the authors note, in sub-Saharan Africa, where 41% of all deaths and 39% of the morbidity burden can potentially be addressed by emergency care, prompt and adequate care can increase the likelihood of survival and recovery. "Pre-hospital care is a vital initial step," say the authors, but is often unavailable until now.

The full guidelines and implementation guide, part of the African First Aid Materials project (AFAM) are available at http://www.afam.redcross.be/

More information: Van de Velde S, De Buck E, Vandekerckhove P, Volmink J (2011) Evidence-Based African First Aid Guidelines and Training Materials. PLoS Med 7(7): e1001059. doi:10.1371/journal.pmed.1001059

Related Stories

First aid for the under 5s

date Feb 28, 2011

One of the reasons often given by people for not attempting first aid in emergency situations is a lack of confidence and a fear of doing more harm than good. Yet a Norwegian study on four and five year olds published in ...

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

date 11 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

date Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.